20 research outputs found

    Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight NCD Risk Factor Collaboration (NCD-RisC)

    Get PDF
    From 1985 to 2016, the prevalence of underweight decreased, and that of obesity and severe obesity increased, in most regions, with significant variation in the magnitude of these changes across regions. We investigated how much change in mean body mass index (BMI) explains changes in the prevalence of underweight, obesity, and severe obesity in different regions using data from 2896 population-based studies with 187 million participants. Changes in the prevalence of underweight and total obesity, and to a lesser extent severe obesity, are largely driven by shifts in the distribution of BMI, with smaller contributions from changes in the shape of the distribution. In East and Southeast Asia and sub-Saharan Africa, the underweight tail of the BMI distribution was left behind as the distribution shifted. There is a need for policies that address all forms of malnutrition by making healthy foods accessible and affordable, while restricting unhealthy foods through fiscal and regulatory restrictions

    Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices

    Get PDF
    Culture of cells using various microfluidic devices is becoming more common within experimental cell biology. At the same time, a technological radiation of microfluidic cell culture device designs is currently in progress. Ultimately, the utility of microfluidic cell culture will be determined by its capacity to permit new insights into cellular function. Especially insights that would otherwise be difficult or impossible to obtain with macroscopic cell culture in traditional polystyrene dishes, flasks or well-plates. Many decades of heuristic optimization have gone into perfecting conventional cell culture devices and protocols. In comparison, even for the most commonly used microfluidic cell culture devices, such as those fabricated from polydimethylsiloxane (PDMS), collective understanding of the differences in cellular behavior between microfluidic and macroscopic culture is still developing. Moving in vitro culture from macroscopic culture to PDMS based devices can come with unforeseen challenges. Changes in device material, surface coating, cell number per unit surface area or per unit media volume may all affect the outcome of otherwise standard protocols. In this review, we outline some of the advantages and challenges that may accompany a transition from macroscopic to microfluidic cell culture. We focus on decisive factors that distinguish macroscopic from microfluidic cell culture to encourage a reconsideration of how macroscopic cell culture principles might apply to microfluidic cell culture

    Open-source milligram-scale, four channel, automated protein purification system.

    No full text
    Liquid chromatography purification of multiple recombinant proteins, in parallel, could catalyze research and discovery if the processes are fast and approach the robustness of traditional, "one-protein-at-a-time" purification. Here, we report an automated, four channel chromatography platform that we have designed and validated for parallelized protein purification at milligram scales. The device can purify up to four proteins (each with its own single column), has inputs for up to eight buffers or solvents that can be directed to any of the four columns via a network of software-driven valves, and includes an automated fraction collector with ten positions for 1.5 or 5.0 mL collection tubes and four positions for 50 mL collection tubes for each column output. The control software can be accessed either via Python scripting, giving users full access to all steps of the purification process, or via a simple-to-navigate touch screen graphical user interface that does not require knowledge of the command line or any programming language. Using our instrument, we report milligram-scale, parallelized, single-column purification of a panel of mammalian cell expressed coronavirus (SARS-CoV-2, HCoV-229E, HCoV-OC43, HCoV-229E) trimeric Spike and monomeric Receptor Binding Domain (RBD) antigens, and monoclonal antibodies targeting SARS-CoV-2 Spike (S) and Influenza Hemagglutinin (HA). We include a detailed hardware build guide, and have made the controlling software open source, to allow others to build and customize their own protein purifier systems

    Build guide.

    No full text
    A detailed guide on how to build the automated protein purifier. (PDF)</p

    High level electronics diagram.

    No full text
    The protein purifier software is executed on a Raspberry Pi, which interfaces with all hardware peripherals through an I2C bus. While most peripherals are powered by a 24 V power supply, a secondary 5 V source generated by a voltage regulator on the Pi hat is used to power both the Raspberry Pi and the solenoid valve controller. The custom hat also uses a level shifter to convert the 3.3 V I2C signal of the Raspberry Pi into a 5 V signal for the attached peripherals.</p

    Parallelized elution profiles.

    No full text
    Fractions in units of column volumes collected over four 1 mL and 5 mL HisTrap™ Excel columns in parallel are shown. PBS was pumped through the columns using both buffer and load flow paths, as indicated in the x-axis labels. Each color corresponds to one channel in each of the conditions.</p

    Single-column flow rate stability.

    No full text
    Relative flow rates over time through 1 mL and 5mL HisTrap™ Excel columns are shown. PBS was pumped through each column using the buffer and load flow paths for a duration of 120 minutes and measured every 10 minutes.</p

    Purity and oligomer analyses of parallel purified coronavirus Spike antigens and antibodies.

    No full text
    A) SARS-CoV-2 Spike RBD, 1 mL HisTrap Excel purification. 10 μL of Load (L) (identical for each channel), flowthrough (F) and elution fractions (1–5) were analyzed by reducing, Coomassie-stained SDS-PAGE. B) mAbs (Anti SARS-CoV-2 Spike and anti Influenza Hemagglutinin) and pAb (healthy serum), 1 mL HiTrap Protein A purification. 10 μL of elution fractions (1–3) were analyzed by Coomassie-stained SDS-PAGE in the presence (+) and in the absence (-) of reducing agent. C-F) Coronavirus Spike antigens, 5 mL HisTrap Excel purification. Parallel purified Coronavirus spike antigens, desalted and concentrated offline, were analyzed by reducing SDS-PAGE (5 μg protein loaded) and analytical SEC-MALS. The calculated molecular weights of the major peak are shown in red.</p
    corecore